HALO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,056,983.70

Halozyme Therapeutics Insider Trading History Chart

Halozyme Therapeutics Share Price & Price History

^$47.79

▼ -1.21 (-2.47%)

As of 11/26/2024 10:04 AM ET

Days: 30 | 90 | 365

Tim Sykes’ Urgent Trade Alert: “Make this move now”

From Timothy Sykes | Ad

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade

Halozyme Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/16/2024	Michael J. LaBarre	SVP	Sell	10,000	$53.26	$532,600.00	173,756
10/9/2024	Helen Torley	CEO	Sell	10,000	$52.58	$525,800.00	676,744
9/25/2024	Helen Torley	CEO	Sell	10,000	$56.34	$563,400.00	676,744
9/18/2024	Michael J. LaBarre	SVP	Sell	10,000	$62.03	$620,300.00	173,756
9/12/2024	Helen Torley	CEO	Sell	10,000	$59.20	$592,000.00	676,744
9/10/2024	Helen Torley	CEO	Sell	10,000	$59.09	$590,900.00	676,744
8/21/2024	Michael J. LaBarre	SVP	Sell	10,000	$61.75	$617,500.00	168,176
8/14/2024	Matthew L. Posard	Director	Sell	9,881	$57.70	$570,133.70	69,874
8/12/2024	Matthew L. Posard	Director	Sell	10,000	$55.72	$557,200.00	89,755
7/24/2024	Michael J. LaBarre	SVP	Sell	10,000	$55.12	$551,200.00	168,176
7/22/2024	Nicole Labrosse	CFO	Sell	5,000	$53.93	$269,650.00	15,480
6/27/2024	Nicole Labrosse	CFO	Sell	10,000	$51.93	$519,300.00	15,480
6/11/2024	Matthew L. Posard	Director	Sell	10,000	$50.01	$500,100.00	109,755
5/22/2024	Michael J. LaBarre	SVP	Sell	10,000	$45.38	$453,800.00	168,176
4/17/2024	Michael J. LaBarre	SVP	Sell	10,000	$38.49	$384,900.00	168,176
3/12/2024	Michael J. LaBarre	SVP	Sell	10,000	$41.64	$416,400.00	156,558
2/28/2024	Michael J. LaBarre	SVP	Sell	10,000	$39.55	$395,500.00	156,558
12/12/2023	Michael J. LaBarre	SVP	Sell	10,000	$39.63	$396,300.00	151,911
10/17/2023	Michael J. LaBarre	SVP	Sell	10,000	$36.52	$365,200.00	151,911
9/19/2023	Michael J. LaBarre	SVP	Sell	10,000	$39.10	$391,000.00	151,911
8/31/2023	Helen Torley	CEO	Sell	10,000	$42.82	$428,200.00	623,666
8/29/2023	Helen Torley	CEO	Sell	10,000	$42.40	$424,000.00	623,666
8/22/2023	Michael J. LaBarre	SVP	Sell	10,000	$42.41	$424,100.00	151,911
8/22/2023	Michael J. LaBarre	SVP	Sell	10,000	$42.41	$424,100.00	151,911
8/17/2023	Helen Torley	CEO	Sell	10,000	$43.18	$431,800.00	623,666
8/14/2023	James M. Daly	Director	Sell	10,000	$43.74	$437,400.00	20,503
8/11/2023	James M. Daly	Director	Sell	10,000	$43.71	$437,100.00	30,503
7/26/2023	Helen Torley	CEO	Sell	10,000	$42.69	$426,900.00	623,666
7/18/2023	Michael J. LaBarre	SVP	Sell	10,000	$40.43	$404,300.00	141,911
6/21/2023	Michael J. LaBarre	SVP	Sell	10,000	$36.00	$360,000.00	141,911
4/18/2023	Michael J. LaBarre	SVP	Sell	10,000	$36.00	$360,000.00	141,911
3/9/2023	Helen Torley	CEO	Sell	10,000	$42.73	$427,300.00	623,666
3/7/2023	Helen Torley	CEO	Sell	10,000	$45.47	$454,700.00	623,666
3/1/2023	Jeffrey William Henderson	Director	Sell	10,000	$47.71	$477,100.00	39,045
2/27/2023	Michael J. LaBarre	SVP	Sell	10,000	$49.55	$495,500.00	138,927
2/16/2023	Helen Torley	CEO	Sell	11,061	$49.26	$544,864.86	633,666
2/16/2023	Nicole Labrosse	CFO	Sell	2,525	$49.26	$124,381.50	9,066
2/15/2023	Michael J. LaBarre	SVP	Sell	10,000	$48.39	$483,900.00	143,477
2/8/2023	Helen Torley	CEO	Sell	10,000	$51.36	$513,600.00	587,177
1/19/2023	Helen Torley	CEO	Sell	10,000	$52.41	$524,100.00	587,177
1/17/2023	Michael J. LaBarre	SVP	Sell	10,000	$50.46	$504,600.00	143,137
12/15/2022	Helen Torley	CEO	Sell	10,000	$57.37	$573,700.00	587,177
12/13/2022	Michael J. LaBarre	SVP	Sell	10,000	$58.67	$586,700.00	153,137
12/5/2022	Matthew L. Posard	Director	Sell	10,000	$55.74	$557,400.00	115,189
12/2/2022	Matthew L. Posard	Director	Sell	10,000	$58.80	$588,000.00	125,189
11/17/2022	Helen Torley	CEO	Sell	10,000	$52.15	$521,500.00	587,177
11/15/2022	Michael J. LaBarre	SVP	Sell	10,000	$54.13	$541,300.00	163,137
11/15/2022	Nicole Labrosse	CFO	Sell	5,000	$53.81	$269,050.00	4,045

Buffett Dumps $982 Million in BofA Stock—What Does He Know?

From Genesis Gold Group | Ad

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now

SEC Filings (Institutional Ownership Changes) for Halozyme Therapeutics (NASDAQ:HALO)

97.79% of Halozyme Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Halozyme Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/25/2024	Synovus Financial Corp	80,590	$4.61M	0.1%	-8.6%	0.063%
11/25/2024	Castellan Group	113,798	$6.51M	2.7%	+4.5%	0.089%
11/25/2024	Tidal Investments LLC	20,576	$1.18M	0.0%	+265.5%	0.016%
11/25/2024	World Investment Advisors LLC	57,526	$3.29M	0.1%	N/A	0.045%
11/25/2024	Sanctuary Advisors LLC	37,039	$2.12M	0.0%	+80.4%	0.029%
11/20/2024	Virtu Financial LLC	7,587	$0.43M	0.0%	N/A	0.006%
11/19/2024	M&T Bank Corp	111,239	$6.37M	0.0%	+0.5%	0.087%
11/18/2024	Teachers Retirement System of The State of Kentucky	42,911	$2.46M	0.0%	-2.5%	0.034%
11/18/2024	Chiron Investment Management LLC	23,502	$1.35M	0.5%	+23.6%	0.018%
11/18/2024	Coldstream Capital Management Inc.	9,251	$0.53M	0.0%	+34.7%	0.007%
11/16/2024	Geode Capital Management LLC	3,060,131	$175.19M	0.0%	+1.0%	2.405%
11/15/2024	M&T Bank Corp	111,239	$6.37M	0.0%	+0.5%	0.087%
11/15/2024	MML Investors Services LLC	9,779	$0.56M	0.0%	+80.7%	0.008%
11/15/2024	Hodges Capital Management Inc.	320,544	$18.35M	1.2%	-5.4%	0.252%
11/15/2024	Pier Capital LLC	144,850	$8.29M	1.2%	-34.3%	0.114%
11/15/2024	Orion Portfolio Solutions LLC	31,113	$1.78M	0.0%	-5.4%	0.024%
11/15/2024	Castleark Management LLC	69,720	$3.99M	0.2%	N/A	0.055%
11/15/2024	EP Wealth Advisors LLC	6,236	$0.36M	0.0%	N/A	0.005%
11/15/2024	Wellington Management Group LLP	65,157	$3.73M	0.0%	-83.6%	0.051%
11/15/2024	Stifel Financial Corp	17,121	$0.98M	0.0%	+126.3%	0.013%
11/15/2024	Janus Henderson Group PLC	545,173	$31.20M	0.0%	+6.2%	0.428%
11/15/2024	HighTower Advisors LLC	36,174	$2.08M	0.0%	+20.2%	0.028%
11/15/2024	ArrowMark Colorado Holdings LLC	2,010,655	$115.09M	1.5%	-3.8%	1.580%
11/15/2024	Erste Asset Management GmbH	47,800	$2.72M	0.0%	N/A	0.038%
11/14/2024	Edgestream Partners L.P.	86,001	$4.92M	0.2%	+116.9%	0.068%
11/14/2024	Caisse DE Depot ET Placement DU Quebec	94,009	$5.38M	0.0%	N/A	0.074%
11/14/2024	Captrust Financial Advisors	24,033	$1.38M	0.0%	-8.8%	0.019%
11/14/2024	Rockefeller Capital Management L.P.	66,038	$3.78M	0.0%	-7.3%	0.052%
11/14/2024	Hantz Financial Services Inc.	161,772	$9.26M	0.2%	N/A	0.127%
11/14/2024	MetLife Investment Management LLC	134,727	$7.71M	0.0%	-1.5%	0.106%
11/14/2024	RPg Family Wealth Advisory LLC	32,942	$1.89M	0.5%	N/A	0.026%
11/14/2024	CreativeOne Wealth LLC	18,089	$1.04M	0.0%	N/A	0.014%
11/13/2024	Glenmede Trust Co. NA	487,131	$27.88M	0.1%	+28.9%	0.383%
11/13/2024	Bridgewater Associates LP	11,515	$0.66M	0.0%	-65.3%	0.009%
11/13/2024	Townsquare Capital LLC	103,223	$5.91M	0.1%	+74.4%	0.081%
11/13/2024	Quantbot Technologies LP	2,614	$0.15M	0.0%	N/A	0.002%
11/13/2024	Advantage Alpha Capital Partners LP	14,738	$0.84M	0.2%	-39.9%	0.012%
11/13/2024	The Manufacturers Life Insurance Company	260,355	$14.90M	0.0%	-1.8%	0.205%
11/13/2024	Harvest Fund Management Co. Ltd	2,849	$0.16M	0.0%	N/A	0.002%
11/13/2024	Fisher Asset Management LLC	324,005	$18.55M	0.0%	+6.8%	0.255%
11/12/2024	Centaurus Financial Inc.	2,219	$0.13M	0.0%	N/A	0.002%
11/12/2024	Alpha DNA Investment Management LLC	9,414	$0.54M	0.2%	+11.1%	0.007%
11/12/2024	Swedbank AB	318,362	$18.22M	0.0%	-4.2%	0.250%
11/12/2024	Charles Schwab Investment Management Inc.	1,773,397	$101.51M	0.0%	-0.8%	1.394%
11/9/2024	Intech Investment Management LLC	56,305	$3.22M	0.0%	+147.4%	0.044%
11/9/2024	Aurora Investment Counsel	32,350	$1.85M	1.0%	-28.3%	0.025%
11/8/2024	Advisors Asset Management Inc.	39,646	$2.27M	0.0%	+5.8%	0.031%
11/8/2024	Commerce Bank	10,701	$0.61M	0.0%	-26.8%	0.008%
11/8/2024	Segall Bryant & Hamill LLC	355,176	$20.33M	0.3%	+16.3%	0.279%
11/8/2024	B. Metzler seel. Sohn & Co. Holding AG	33,183	$1.90M	0.0%	N/A	0.026%
11/8/2024	Wrapmanager Inc.	5,086	$0.29M	0.1%	-26.7%	0.004%
11/7/2024	Quest Partners LLC	9,793	$0.56M	0.0%	+1,386.0%	0.008%
11/7/2024	TrinityPoint Wealth LLC	3,737	$0.21M	0.0%	N/A	0.003%
11/7/2024	Swiss National Bank	248,600	$14.23M	0.0%	-0.5%	0.195%
11/7/2024	Thrivent Financial for Lutherans	233,016	$13.34M	0.0%	-75.3%	0.183%
11/6/2024	Mutual of America Capital Management LLC	178,688	$10.23M	0.1%	-2.9%	0.141%
11/6/2024	South Street Advisors LLC	171,415	$9.81M	1.5%	N/A	0.135%
11/6/2024	Natixis Advisors LLC	121,560	$6.96M	0.0%	+86.7%	0.096%
11/6/2024	Mizuho Markets Americas LLC	375,446	$21.49M	0.4%	-14.3%	0.296%
11/6/2024	Koa Wealth Management LLC	74,483	$4.26M	3.3%	+1.2%	0.059%
11/6/2024	Sheaff Brock Investment Advisors LLC	7,118	$0.41M	0.0%	+7.7%	0.006%
11/6/2024	Royce & Associates LP	124,011	$7.10M	0.1%	-29.8%	0.098%
11/6/2024	Cornercap Investment Counsel Inc.	8,007	$0.46M	0.1%	-71.6%	0.006%
11/6/2024	CIBC Asset Management Inc	3,691	$0.21M	0.0%	N/A	0.003%
11/6/2024	OneDigital Investment Advisors LLC	10,120	$0.58M	0.0%	-5.1%	0.008%
11/5/2024	Chase Investment Counsel Corp	93,601	$5.36M	1.8%	+2.5%	0.074%
11/5/2024	Future Fund LLC	11,096	$0.63M	1.9%	-69.4%	0.009%
11/5/2024	Victory Capital Management Inc.	406,811	$23.29M	0.0%	-96.6%	0.321%
11/5/2024	GSA Capital Partners LLP	3,790	$0.22M	0.0%	N/A	0.003%
11/5/2024	WCM Investment Management LLC	300,045	$17.09M	0.0%	-3.5%	0.237%
11/5/2024	Nations Financial Group Inc. IA ADV	13,734	$0.79M	0.1%	+6.3%	0.011%
11/4/2024	Los Angeles Capital Management LLC	110,630	$6.33M	0.0%	-4.9%	0.087%
11/4/2024	State of New Jersey Common Pension Fund D	47,361	$2.71M	0.0%	-3.7%	0.037%
11/2/2024	Covestor Ltd	1,777	$0.10M	0.1%	-13.4%	0.001%
11/1/2024	Atria Investments Inc	13,065	$0.75M	0.0%	-12.8%	0.010%
11/1/2024	Assetmark Inc.	93,159	$5.33M	0.0%	+9.9%	0.074%
11/1/2024	Verdence Capital Advisors LLC	13,232	$0.76M	0.1%	+1.9%	0.010%
11/1/2024	Verity Asset Management Inc.	38,248	$2.19M	0.8%	-5.8%	0.030%
10/31/2024	Portside Wealth Group LLC	9,123	$0.52M	0.1%	+132.1%	0.007%
10/31/2024	Kornitzer Capital Management Inc. KS	441,864	$25.29M	0.5%	-15.5%	0.347%
10/31/2024	Principal Financial Group Inc.	448,087	$25.65M	0.0%	-25.7%	0.352%
10/31/2024	Hanseatic Management Services Inc.	10,153	$0.58M	0.8%	N/A	0.008%
10/30/2024	Foster & Motley Inc.	10,650	$0.61M	0.0%	N/A	0.008%
10/30/2024	Amalgamated Bank	58,041	$3.32M	0.0%	-5.9%	0.046%
10/30/2024	Catalyst Capital Advisors LLC	33,965	$1.94M	0.0%	N/A	0.027%
10/30/2024	QRG Capital Management Inc.	4,279	$0.25M	0.0%	N/A	0.003%
10/29/2024	Van ECK Associates Corp	11,616	$0.67M	0.0%	-35.5%	0.009%
10/29/2024	Janney Montgomery Scott LLC	36,020	$2.06M	0.0%	+38.4%	0.028%
10/29/2024	VELA Investment Management LLC	12,729	$0.73M	0.2%	N/A	0.010%
10/29/2024	James Investment Research Inc.	29,075	$1.66M	0.2%	+37.3%	0.023%
10/29/2024	Farther Finance Advisors LLC	1,620	$93K	0.0%	+173.6%	0.001%
10/28/2024	Stephens Investment Management Group LLC	1,359,730	$77.83M	1.1%	-4.4%	1.068%
10/28/2024	Oak Ridge Investments LLC	60,340	$3.45M	0.3%	-3.9%	0.047%
10/28/2024	Congress Asset Management Co.	2,433,579	$139.30M	0.9%	+446.5%	1.912%
10/28/2024	Meitav Investment House Ltd.	63,000	$3.61M	0.1%	N/A	0.049%
10/25/2024	Diversify Wealth Management LLC	9,439	$0.54M	0.0%	+28.8%	0.007%
10/25/2024	New York State Teachers Retirement System	127,327	$7.29M	0.0%	+12.8%	0.100%
10/25/2024	AMI Asset Management Corp	48,944	$2.80M	0.2%	-13.6%	0.038%
10/25/2024	Davidson Capital Management Inc.	26,813	$1.54M	0.4%	+14,012.1%	0.021%
10/25/2024	Diversify Advisory Services LLC	5,331	$0.31M	0.0%	+8.5%	0.004%

Data available starting January 2016

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.

Today's Range

Now: $47.79

$47.79

50 Day Range

MA: $54.28

$42.57

$62.31

52 Week Range

Now: $47.79

$33.15

$65.53

Volume

1,124 shs

Average Volume

1,371,000 shs

Market Capitalization

$6.08 billion

P/E Ratio

15.82

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Halozyme Therapeutics?: Halozyme Therapeutics' top insider shareholders include:
Helen Torley (CEO)
Michael J Labarre (SVP)
Matthew L Posard (Director)
Jeffrey William Henderson (Director)
James M Daly (Director)
Nicole Labrosse (CFO)
Learn More about top insider investors at Halozyme Therapeutics.
Who are the major institutional investors of Halozyme Therapeutics?: Halozyme Therapeutics' top institutional investors include:
Geode Capital Management LLC — 2.41%
Congress Asset Management Co. — 1.91%
ArrowMark Colorado Holdings LLC — 1.58%
Handelsbanken Fonder AB — 1.55%
Charles Schwab Investment Management Inc. — 1.39%
Stephens Investment Management Group LLC — 1.07%
Learn More about top institutional investors of Halozyme Therapeutics stock.
Which major investors are selling Halozyme Therapeutics stock?: Within the last quarter, HALO stock was sold by these institutional investors:
Victory Capital Management Inc.
Thrivent Financial for Lutherans
Wellington Management Group LLP
Principal Financial Group Inc.
Kornitzer Capital Management Inc. KS
ArrowMark Colorado Holdings LLC
Allspring Global Investments Holdings LLC
Pier Capital LLC
In the last year, company insiders that have sold Halozyme Therapeutics company stock include:
Helen Torley (CEO)
Michael J Labarre (SVP)
Matthew L Posard (Director)
Jeffrey William Henderson (Director)
Learn More investors selling Halozyme Therapeutics stock.
Which major investors are buying Halozyme Therapeutics stock?: Within the last quarter, HALO stock was acquired by institutional investors including:
Congress Asset Management Co.
Handelsbanken Fonder AB
Boston Trust Walden Corp
South Street Advisors LLC
Hantz Financial Services Inc.
Raymond James & Associates
Glenmede Trust Co. NA
Caisse DE Depot ET Placement DU Quebec